At baseline, these 2 participants (who continued to need diabetes medications at 3 months) were on metformin plus a SGLT-2i and metformin plus insulin; 1 participant was an African American male with a preoperative BMI of 60 kg/m2 and the other was a 19-year-old Hispanic female with a diabetes duration of 50 months. Here, INS is linked to diabetes mellitus.